Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer

T. A. Augustine, M. Baig, A. Sood, T. Budagov, G. Atzmon, J. M. Mariadason, S. Aparo, R. Maitra, S. Goel

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences